Fig. 5
From: Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
High RAD51 expression indicates increased chemoresistance in ovarian cancer. In DepMap, drug sensitivity level dose was used to evaluate drug sensitivity, namely, the higher the drug sensitivity level dose was, the more resistant the cell line. Correlation analysis between RAD51 gene effect and drug sensitivity level dose of ovarian cancer lines to a cisplatin, b carboplatin, c paclitaxel, and d docetaxel was performed (Pearson’s correlation test)